# Protez Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/protez-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Malvern, US
- Website: www.protez.com
- Total disclosed funding: $22M
- Latest round: Series B (Apr 25, 2006)
- Investors on record: 9

## About

Protez Pharmaceuticals, Inc. engages in the development and commercialization of antibiotics drugs.

## Funding rounds

- Series B, Apr 25, 2006, $6M — Quaker Partners Management, Easton Capital Investment Group, L Capital Partners, Illinois Finance Authority, Birchmere, BTG International Inc.
- Series B, Aug 25, 2005, $16M — Quaker Partners Management, BTG, SR One, L Capital Partners, BioAdvance, Illinois Finance Authority, Birchmere
- Seed, Dec 1, 2003, $0.5M — BioAdvance

## Investors

- BioAdvance (https://capitalatlas.ai/funds/bioadvance) — Seed, Series B
- Quaker Partners Management (https://capitalatlas.ai/funds/quaker-partners-management) — Series B
- BTG — Series B
- SR One (https://capitalatlas.ai/funds/sr-one) — Series B
- L Capital Partners (https://capitalatlas.ai/funds/l-capital-partners) — Series B
- Illinois Finance Authority — Series B
- Birchmere (https://capitalatlas.ai/funds/birchmere) — Series B
- Easton Capital Investment Group (https://capitalatlas.ai/funds/easton-capital-investment-group) — Series B
- BTG International Inc. — Series B